Next Article in Journal
Reply to Karademir, F.; Fírat, T. Comment on “Covelli et al. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453”
Previous Article in Journal
Technical and Performance Characteristics Between Different Anti-Mullerian Hormone (AMH) Assay Methods and Antral Follicle Count (AFC) in Malaysian Women with Infertility: A University-Based Centre Cohort
 
 
Reply published on 28 February 2025, see Life 2025, 15(3), 385.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

Comment on Covelli et al. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453

Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Department of Hand Surgery and Rehabilitation, 06100 Ankara, Turkey
*
Author to whom correspondence should be addressed.
Life 2025, 15(3), 384; https://doi.org/10.3390/life15030384
Submission received: 17 December 2024 / Accepted: 24 February 2025 / Published: 28 February 2025
(This article belongs to the Section Medical Research)
We read the study by Covelli et al. [1] with great interest. We appreciate the authors for their contribution. However, we would like to address some methodological concerns that we believe warrant attention.
The primary aim of this study, as stated in the article, is to compare the effects of Extracorporeal Shock Wave Therapy (ESWT) versus exercise in patients with trapeziometacarpal osteoarthritis (TMC OA). However, the statistical approach used to analyze the results appears misaligned with the aim of the study. Specifically, the study used a four-way repeated-measures Wilcoxon test for each group, which does not allow for an appropriate comparison of treatment efficacy between the two modalities. Given that two different interventions (ESWT and exercise) were being compared, a two-way repeated-measures ANOVA would have been a more appropriate statistical method to accurately assess treatment effectiveness and time by treatment interactions. Furthermore, the regression analyses provided (both multivariable and univariable) do not appear to clarify or address the comparisons of treatment effects between the two modalities. It is essential that statistical analyses accurately reflect the study design and aim to avoid generating misleading conclusions.
Another issue of concern is the use of ultrasound to guide the application of ESWT. The article mentions that the probe used for ESWT was large in size and that the trapeziometacarpal (TMC) joint was identified using ultrasound to guide the therapy. However, the TMC joint is not particularly difficult to palpate or anatomically identify, which raises questions about the need for ultrasound in this study. The rationale for using ultrasound remains unclear, and it is important to justify the choice of this technique. If the goal was to ensure precision in targeting the treatment area, the authors should have provided further explanation of the specific advantages of using ultrasound over traditional palpation methods. Additionally, if precision was indeed the primary concern, one would expect a more detailed discussion of the ESWT application technique itself, including its indications and how it was optimized for TMC OA.
Finally, the Discussion section does not explain why ESWT was specifically chosen as a treatment modality for TMC OA. While the authors briefly mention the general mechanism of ESWT in terms of pain inhibition, the article does not adequately address the unique pathophysiology of TMC OA. The mechanism of action of ESWT in TMC OA has not been sufficiently investigated, resulting in a gap in understanding the rationale behind the preference for this treatment over other alternatives. A more focused discussion on how ESWT interacts with the specific biological processes involved in TMC OA, such as cartilage degradation, osteophyte formation, or joint instability, would provide greater insight into the relevance of this treatment choice.
In conclusion, while this study offers valuable insights into the comparison of ESWT and exercise therapy for TMC OA, we hope that the aforementioned issues will be addressed in future revisions or discussions, since doing so would enhance the overall validity and impact of the findings.

Author Contributions

Writing—review and editing, F.K.; supervision, T.F. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Covelli, I.; De Giorgi, S.; Di Lorenzo, A.; Pavone, A.; Salvato, F.; Rifino, F.; Moretti, B.; Solarino, G.; Notarnicola, A. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Karademir, F.; Fírat, T. Comment on Covelli et al. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453. Life 2025, 15, 384. https://doi.org/10.3390/life15030384

AMA Style

Karademir F, Fírat T. Comment on Covelli et al. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453. Life. 2025; 15(3):384. https://doi.org/10.3390/life15030384

Chicago/Turabian Style

Karademir, Feray, and Tüzün Fírat. 2025. "Comment on Covelli et al. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453" Life 15, no. 3: 384. https://doi.org/10.3390/life15030384

APA Style

Karademir, F., & Fírat, T. (2025). Comment on Covelli et al. Extracorporeal Shock Wave Therapy (ESWT) vs. Exercise in Thumb Osteoarthritis (SWEX-TO): Prospective Clinical Trial at 6 Months. Life 2024, 14, 1453. Life, 15(3), 384. https://doi.org/10.3390/life15030384

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop